Literature DB >> 6328863

Distribution of collagen types I, III, and V in fibrotic and neoplastic human liver.

M Yamamoto, H Sumiyoshi, K Nakagami, E Tahara.   

Abstract

The distribution of collagen types I, III, and V in normal and fibrotic human livers and hepatocellular carcinoma was studied by indirect immunofluorescence procedure using type specific antibodies. Type I collagen as well as type III collagen was present in normal liver within the portal tracts and along the perisinusoidal spaces. Basement membrane collagen, type V collagen, was demonstrated only around the bile ducts and vessels of the portal tracts and central veins. In fibrotic liver, both type I and III collagens were found in increased amounts in fibrotic areas. In fibrous septa of active cirrhosis, however, type I collagen as well as type III collagen was abundant, whereas in inactive cirrhosis type I fibers were predominant. Type V collagen was observed in the walls of proliferative bile ductules and vessels in the fibrotic liver, and also along the sinusoids in the periportal areas. In hepatocellular carcinoma, each type of collagen was distributed regularly along the sinusoid-like vascular channels within the tumor.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6328863     DOI: 10.1111/j.1440-1827.1984.tb02184.x

Source DB:  PubMed          Journal:  Acta Pathol Jpn        ISSN: 0001-6632


  9 in total

1.  A comparison of the immunofluorescent localization of collagen types I, III, and V with the distribution of reticular fibers on the same liver sections of the snow monkey (Macaca fuscata).

Authors:  E Adachi; T Hayashi; P H Hashimoto
Journal:  Cell Tissue Res       Date:  1991-04       Impact factor: 5.249

2.  Evaluating the antifibrotic potency of galunisertib in a human ex vivo model of liver fibrosis.

Authors:  Theerut Luangmonkong; Su Suriguga; Emilia Bigaeva; Miriam Boersema; Dorenda Oosterhuis; Koert P de Jong; Detlef Schuppan; Henricus A M Mutsaers; Peter Olinga
Journal:  Br J Pharmacol       Date:  2017-08-11       Impact factor: 8.739

3.  Immune response to extracellular matrix collagen in chronic hepatitis C-induced liver fibrosis.

Authors:  Brian B Borg; Anil Seetharam; Vijay Subramanian; Haseeb Ilias Basha; Mauricio Lisker-Melman; Kevin Korenblat; Christopher D Anderson; Surendra Shenoy; William C Chapman; Jeffrey S Crippin; Thalachallour Mohanakumar
Journal:  Liver Transpl       Date:  2011-07       Impact factor: 5.799

4.  Distribution of collagen types I and III and basal lamina in human gastric carcinoma: an immunohistochemical and electron microscopic study.

Authors:  M Yamamoto; H Sumiyoshi; K Nakagami; K Taniyama; E Tahara
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1984

5.  Evaluation of hepatocellular carcinoma aggressiveness by a panel of extracellular matrix antigens.

Authors:  W F Grigioni; S Garbisa; A D'Errico; P Baccarini; W G Stetler-Stevenson; L A Liotta; A M Mancini
Journal:  Am J Pathol       Date:  1991-03       Impact factor: 4.307

6.  Neoplastic association of enhanced type V collagen production in rat fibrosarcoma.

Authors:  R Asokan; G K Reddy; S C Dhar
Journal:  Mol Cell Biochem       Date:  1993-03-10       Impact factor: 3.396

7.  Purification and characterization of collagens from rat fibrosarcoma induced by 3-methylcholanthrene.

Authors:  R Asokan; R Puvanakrishnan; L V Ravichandran; V Kokila; G K Reddy; S C Dhar
Journal:  Mol Cell Biochem       Date:  1993-04-21       Impact factor: 3.396

8.  Anti-fibrotic effect of rosmarinic acid on inhibition of pterygium epithelial cells.

Authors:  Ya-Yu Chen; Chia-Fang Tsai; Ming-Chu Tsai; Wen-Kang Chen; Yu-Wen Hsu; Fung-Jou Lu
Journal:  Int J Ophthalmol       Date:  2018-02-18       Impact factor: 1.779

9.  Extravasated platelet aggregation in liver zone 3 may correlate with the progression of sinusoidal obstruction syndrome following living donor liver transplantation: A case report.

Authors:  Shinichi Nakanuma; Tomoharu Miyashita; Hironori Hayashi; Hidehiro Tajima; Hiroyuki Takamura; Tomoya Tsukada; Koichi Okamoto; Seisho Sakai; Isamu Makino; Jun Kinoshita; Keishi Nakamura; Katsunobu Oyama; Masafumi Inokuchi; Hisatoshi Nakagawara; Itasu Ninomiya; Hirohisa Kitagawa; Sachio Fushida; Takashi Fujimura; Tetsuo Ohta
Journal:  Exp Ther Med       Date:  2015-02-02       Impact factor: 2.447

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.